Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_assertion type Assertion NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_head.
- NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_assertion description "[A 9-year-old girl who had hepatitis-associated aplastic anemia was treated intermittently with methylprednisolone pulse therapy and growth factors (granulocyte-colony stimulating factor (G-CSF), recombinant human erythropoietin (rhEpo) and cyclosporin A (CyA) for over two years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_provenance.
- NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_assertion evidence source_evidence_literature NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_provenance.
- NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_assertion SIO_000772 12850817 NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_provenance.
- NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_assertion wasDerivedFrom befree-2016 NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_provenance.
- NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_assertion wasGeneratedBy ECO_0000203 NP401235.RAkpnu3gq7q-ej6tEj8U_xLWwxDF6LGDFatm6v5Npzii4130_provenance.